OCULAR THERAPEUTIX, INChttps://pcaobus.org/form-ap-filings/54438/54438OCULAR THERAPEUTIX, INC544384/4/2020 5:29:00 PM201914659bf9-984f-43af-8889-339bcfdfc14b238PricewaterhouseCoopers LLP381643OCULAR THERAPEUTIX, INC1393434OCUL0023800611Mark Stephen Barsanti0023800611True
Solid Biosciences Inc.https://pcaobus.org/form-ap-filings/54349/54349Solid Biosciences Inc.543494/4/2020 12:22:00 PM2019d72cd371-98f0-483b-85e1-6dd695fb191a238PricewaterhouseCoopers LLP699644Solid Biosciences Inc.1707502SLDB0023800611Mark Stephen Barsanti0023800611True
Surface Oncology, Inc.https://pcaobus.org/form-ap-filings/54351/54351Surface Oncology, Inc.543514/4/2020 12:22:00 PM201947f1ab3b-d035-4da7-91df-aa3a9ac7d5b4238PricewaterhouseCoopers LLP705429Surface Oncology, Inc.1718108SURF0023800611Mark Stephen Barsanti0023800611True
Seres Therapeutics, Inc.https://pcaobus.org/form-ap-filings/52345/52345Seres Therapeutics, Inc.523453/19/2020 9:15:14 AM20192163a04d-f95d-4fda-a792-650b0a00906f238PricewaterhouseCoopers LLP589716Seres Therapeutics, Inc.1609809MCRB0023800611Mark Stephen Barsanti0023800611True
MERRIMACK PHARMACEUTICALS INChttps://pcaobus.org/form-ap-filings/38698/38698MERRIMACK PHARMACEUTICALS INC386984/10/2019 1:56:08 PM20186c6fd25d-13fa-4d36-86dd-86152e3b8628238PricewaterhouseCoopers LLP262379MERRIMACK PHARMACEUTICALS INC1274792MACK0023800611Mark Stephen Barsanti0023800611True
Solid Biosciences Inc.https://pcaobus.org/form-ap-filings/36978/36978Solid Biosciences Inc.369783/27/2019 8:12:07 AM2018e0bea847-dc95-43ea-ae38-75cea1960bc4238PricewaterhouseCoopers LLP699644Solid Biosciences Inc.1707502SLDB0023800611Mark Stephen Barsanti0023800611True
Surface Oncology, Inc.https://pcaobus.org/form-ap-filings/36855/36855Surface Oncology, Inc.368553/26/2019 3:40:58 PM201874eb3322-5564-4f30-9f4d-e1c69f6ccfcd238PricewaterhouseCoopers LLP705429Surface Oncology, Inc.1718108SURF0023800611Mark Stephen Barsanti0023800611True
OCULAR THERAPEUTIX, INChttps://pcaobus.org/form-ap-filings/36821/36821OCULAR THERAPEUTIX, INC368213/26/2019 3:38:10 PM2018dcb2c340-6252-4c31-8be4-57c59789cdcc238PricewaterhouseCoopers LLP381643OCULAR THERAPEUTIX, INC1393434OCUL0023800611Mark Stephen Barsanti0023800611True
Seres Therapeutics, Inc.https://pcaobus.org/form-ap-filings/36831/36831Seres Therapeutics, Inc.368313/26/2019 3:38:10 PM20184257bd01-c700-49b0-a87d-31ee2ef6b07d238PricewaterhouseCoopers LLP589716Seres Therapeutics, Inc.1609809MCRB0023800611Mark Stephen Barsanti0023800611True
Solid Biosciences Inc.https://pcaobus.org/form-ap-filings/22529/22529Solid Biosciences Inc.225294/16/2018 9:29:07 AM2017bb921e7e-b314-4dde-a7ea-dc8f7e35ba83238PricewaterhouseCoopers LLP699644Solid Biosciences Inc.1707502SLDB0023800611Mark Stephen Barsanti0023800611True